ACI Files Comments to the US Customs and Border Protection: Uphold STOP Act Provisions

Re: Mandatory Advance Electronic Information for International Mail Shipments Interim Final Rule; Docket No. USCBP-2021-0009 CBP Dec. 21-04 To the attention of Secretary Mayorkas: The American Consumer Institute Center for Citizen Research (ACI) would like to take the opportunity to address the Mandatory Advance Electronic Information for International Mail Shipments interim final rule (IFR) issued […]

House Bill Could Prevent Patients from Accessing Lifesaving Medications

In late April, Democratic representative Frank Pallone (D-NJ06) re-introduced the Lower Drug Costs Now Act (LDCNA) to the House of Representatives. If passed, the bill would lower prices for medications by placing price controls on prescription drugs sold in the United States. Americans spent an average of $1,200  for prescriptions in 2020, which the bill’s […]

Podcast on Drug Pricing Reform: Good Ideas and Bad Ideas — with Dr. Robert Popovian

Description:  Rising drug prices continue to be a top concern for Americans. In response, members of Congress are floating multiple recycled ideas that revolve around price controls. In this episode, Dr. Robert Popovian, the Founder of the strategic consulting firm Conquest Advisors, Senior Health Policy Fellow at the Progressive Policy Institute, and previously the Vice […]

ACI Sends a Letter to Senate and House Leadership: HR3 Will Create Drug Shortages

Dear Senate Majority Leader Schumer, House Speaker Pelosi, Senate Republican Leader McConnell, and House Republican Leader McCarthy: As you tackle prescription drug affordability, we urge Congress to remove any international reference pricing proposals out of drug pricing reform legislation. Failure to do so will have the opposite effect of rising healthcare costs for Americans and […]

Coalition Letter Opposes Price Regulation of Lower Priced Generic Drugs

Dear Members of the Committee on Health Coverage, Insurance and Financial Services: As state and national organizations representing a wide range of U.S. taxpayers and consumers, we write today in opposition to LD 1117, Maine’s Act To Prevent Excessive Prices for Prescription Drugs, which seeks to impose pricing constraints on generic drug manufacturers. While working […]

Preemptions on E-Cigarettes Improve Consumer Health

This January, South Carolina became the most recent state to propose imposing preemptive legislation that would prohibit local municipalities from enforcing flavor bans and restricting the sale of electronic cigarettes. The proposal to introduce a preemption on electronic cigarettes products came after the Myrtle Beach city council banned the sale of flavored electronic cigarettes along […]

Want Lower Drug Costs? Increase Generic Competition

The list price of prescription drugs has already risen this year an average of 4.5%, with most of the increases coming from drugs that do not have a generic alternative. These price increases impose a greater burden on the 25% of Americans who already struggle to afford their medicines. The Kaiser Family Foundation found in […]

OECD Minimum Tax Rate Hurts the U.S. Economy

Last year, the Organization for Economic Cooperation and Development (OECD) announced its two-pillar proposal to pursue the goals of transferring tax rights between nations, targeting profits of larger companies and multinational corporations, and instituting a cross-border minimum tax rate. The G-20 is gearing up for a meeting to discuss the first pillar of placing a […]

It’s Time to Reform Free-Standing Emergency Rooms

According to data from the Centers for Disease Control, there were 130 million visits to emergency departments in 2020. Despite the significant number of visits to emergency rooms, not all visits occurred at traditional emergency departments, but rather at free-standing emergency departments not physically connected to a hospital. Between 2008 and 2016, the number of […]

Illicit Tobacco Trade Networks Could Be Contributing To Ongoing Pandemic PPE Fraud

The COVID-19 pandemic has seen a dramatic increase in counterfeit products and fraudulent retail transactions across the globe. In business-to-business markets, employers are getting scammed by fraudsters who successfully peddle counterfeit PPE equipment and face masks. Entire hospitals and medical facilities were duped into purchasing sub-par PPE, among other similar scenarios that impact consumers of […]